J1050 HCPCS code: Injection, medroxyprogesterone acetate, 1 mg
J1050 is the HCPCS Level II code for injection, medroxyprogesterone acetate, 1 mg. In 2024 Medicare paid an average of $0.18 per service for J1050 across 796,072 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1000 per day on outpatient hospital claims. Medicare volume fell 35% from 2022 to 2024 (1,224,105 to 796,072 services). In 2024, about 2,704 clinicians billed Medicare for J1050 for 2,754 beneficiaries; Texas, Arkansas, Colorado accounted for 27% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2013-01-01 |
| Last action effective | 2013-01-01 |
Who bills J1050 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2,704 |
| Medicare beneficiaries | 2,754 |
| States with claims | 40 |
| Share of services in top 3 states (Texas, Arkansas, Colorado) | 27% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1050, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,224,105 | 4,437 | $0.40 | $0.25 |
| 2023 | 829,745 | 2,912 | $0.24 | $0.17 |
| 2024 | 796,072 | 2,754 | $0.26 | $0.18 |
States with the most J1050 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 94,161 | $0.02 |
| Arkansas | 58,459 | $0.01 |
| Colorado | 58,079 | $0.01 |
| Pennsylvania | 54,500 | $0.01 |
| Ohio | 37,162 | $0.26 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 1000 | Prescribing Information |
| practitioner claims | 1000 | Prescribing Information |
What changed for J1050
- 2013-01-01: J1050 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1050?
J1050 is the HCPCS Level II code for injection, medroxyprogesterone acetate, 1 mg. Short descriptor: "Medroxyprogesterone acetate".
How much does Medicare pay for J1050?
In 2024, the average Medicare payment was $0.18 per service (average allowed $0.26).
Does Medicare cover J1050?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1050 can be billed per day?
1000 on outpatient hospital claims; 1000 on practitioner claims (NCCI medically unlikely edits).
Related J10 codes
- J1000 — Injection, depo-estradiol cypionate, up to 5 mg
- J1010 — Injection, methylprednisolone acetate, 1 mg
- J1020 — Injection, methylprednisolone acetate, 20 mg
- J1030 — Injection, methylprednisolone acetate, 40 mg
- J1040 — Injection, methylprednisolone acetate, 80 mg
- J1060 — Injection, testosterone cypionate and estradiol cypionate, up to 1 ml
- J1070 — Injection, testosterone cypionate, up to 100 mg
- J1071 — Injection, testosterone cypionate, 1 mg
- J1072 — Injection, testosterone cypionate (azmiro), 1 mg
- J1073 — Testosterone pellet, implant, 75 mg
- J1080 — Injection, testosterone cypionate, 1 cc, 200 mg
- J1094 — Injection, dexamethasone acetate, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1050
- Watch J1050 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1050
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.